Origin Therapeutics Sponsoring Microdose Psychedelic Capital Conference
Origin Therapeutics’ portfolio company, Microdose Psychedelic Insights, will host the Microdose Psychedelic Capital event virtually on March 24Vancouver, British Columbia,...
Day: March 23, 2022
Cost, Access are Biggest Barriers to OUD Recovery, But Telemedicine Can Help, According to New Report from Bicycle Health
100% of respondents believe that telemedicine-supported Medication-Assisted Treatment should remain available even after the pandemic comes to an endBOSTON, March...
Novolyze Raises $15 Million to Improve Food Safety Globally
BETHESDA, Md., March 23, 2022 (GLOBE NEWSWIRE) -- Bethesda, Maryland- and Dijon, France-based food safety and quality scale-up Novolyze announced today...
TransCode Therapeutics Announces Article Published in the Journal Cancers Detailing the Potential for Short RNA-based Drugs in Cancer and a Broad Range of Disorders
BOSTON, March 23, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer...
Exhale Wellness: 50 States Legal Weed Cannabinoid Stirs up the Cannabis Industry
GLENDALE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- A large number of legal hemp suppliers satisfy the appetites of hemp...
Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual Meeting
Anika is an innovative joint preservation company focused on the early intervention orthopedic continuum of care including OA pain management,...
Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 2022, at 12:00 pm ET
MINNEAPOLIS, March 23, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
Heat Biologics Announces Appointment of Greg Burel, Former Director of the Strategic National Stockpile, to its Biothreat Advisory Board and as Senior Advisor to the Company
Burel to support anthrax and RapidVax™ biodefense initiatives as a platform for rapid response to known and unknown biological threatsDURHAM,...
Allogene Therapeutics Announces Preclinical Publication Highlighting Superiority of Healthy Donor-Derived Allogeneic CAR T Cells Over Patient-Derived Cells in Multiple Myeloma
Results Demonstrated Anti-BCMA CAR T Cells Derived from Healthy Donors Had Better Immune Fitness and Killing ActivityPhase 1 AlloCAR T™...
AIM ImmunoTech to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
Company to participate in live panel, “Pancreatic Cancer: Turning the Tide for One of the Most Challenging Indications in Oncology,”...
TRACON Pharmaceuticals to Present at the Maxim Group 2022 Virtual Growth Conference
SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Onconova Therapeutics to Present at the Next Generation Kinase Inhibitors Summit
NEWTOWN, Pa., March 23, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering...
Atreca to Host Virtual R&D Day on Tuesday, April 5, 2022
SAN CARLOS, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on...
ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS
Arecor Therapeutics plc(“Arecor” or the “Group”) ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS Further strengthens the Company’s extensive...
Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
Oak Ridge, TN, March 23, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
SAN JOSE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a...
RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol
Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in...
Ventyx Biosciences Reports Full Year 2021 Financial Results and Highlights Recent Corporate Progress
Topline Phase 1 data for our allosteric TYK2 inhibitor, VTX958, expected in early Q3 2022 Topline Phase 1 data for...
electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York
ROCKAWAY, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today...
LifeMD Launches Proprietary Over-the-Counter Skincare Line for Women, Expanding Teledermatology Offerings
NavaMD’s clinically studied, OTC skincare platform is protected by a global intellectual property portfolio and $50+ Million of third-party capital...
